Navigation Links
Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for its Third Quarter of FY 2009
Date:5/13/2009

LAIYANG, China, May 13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc., (OTC Bulletin Board: JGBO; "Jiangbo" or the "Company") (which recently changed its name from Genesis Pharmaceuticals Enterprises, Inc., OTC Bulletin Board: GNPH), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that the Company will host a conference call at 9:30 a.m. Eastern on Tuesday, May 19, 2009 to discuss financial results for the third quarter ended March 31, 2009 of its fiscal year 2009.

Conference Call

The conference call will include Mr. Wubo Cao, Chairman and CEO, Mr. Haibo Xu, COO, and Ms. Elsa Sung, CFO, of Jiangbo Pharmaceuticals.

To participate in this live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: (888) 481-7939. International callers should call (617) 847-8707. The Conference Passcode is 564 145 01.

If you are unable to participate in the call at that time, replay of the conference call will be available from Tuesday, May 19, 2009 at 11:30 a.m. Eastern for fourteen days. To access the replay, call (888) 286-8010. International callers should call (617) 801-6888. The Conference Replay Passcode is 547 268 69.

About Jiangbo Pharmaceuticals, Inc.

Jiangbo Pharmaceuticals, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong province. Jiangbo is a major pharmaceutical company in China producing both western and Chinese herbal-based medical drugs in tablet, capsule, granule, and electuary (sticky syrup) form.

Safe Harbor Statement

Certain statements in this press release that are not h
'/>"/>

SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name
2. Jiangbo Pharmaceuticals Announces New Ticker (JGBO) and CUSIP
3. Jiangbo Pharmaceuticals, Inc. to Present at CCG IRs China Rising Conference in New York
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
6. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
9. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
10. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
11. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Funeral Financials is encouraging ... to the EOD Memorial Foundation Funeral Financials ... greatest victims from the war. , According to ... 1941 before the U.S. was even at war. ... identified with the Explosive Ordnance Disposal Badge. EOD technicians ...
(Date:5/23/2013)... Da Vinci surgical robot maker Intuitive Surgical ... State May 23, according to Bloomberg.* The Rottenstein Law ... lawsuits , expresses disappointment in the ruling but encourages ... read a single verdict as representative of all da ... Taylor v. Intuitive Surgical Inc.; 09-2-03136-5, Superior Court, Port ...
(Date:5/23/2013)... Mann HealthDay Reporter , , THURSDAY, May 23 ... take to help treat hip and knee osteoarthritis may ... for developing glaucoma, a small new study of older ... an increase of intraocular pressure (IOP) or pressure inside ... leading causes of blindness. In the ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- People who eat ... they realize -- and teens are the worst offenders, ... of calories in their meals by as much as ... as 23 percent, and adults by as much as ... in a news release from the Robert Wood Johnson ...
(Date:5/23/2013)... a woman harried by hot flashes says she,s having ... online in Menopause , the journal of The ... tests that what these women say about their memory ... that hot flashes were related to memory problems, and ... was a relationship between hot flashes and what women ...
Breaking Medicine News(10 mins):Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 2Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 3Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2
... NASHVILLE, Tenn. and GLEN ROCK, N.J., Aug. 6 ... of surveyed pharmacy directors say that by 2014 they ... preferred biologic for all immune conditions, such as rheumatoid ... the new Formulary Forum report entitled Formulary Advantages ...
... , , , , ... growing social network for physicians , announced today the addition ... to its leadership team. Mr. Chase joins iMedExchange as Vice President ... Pharmaceutical, Medical Device and Luxury Goods and Services companies. , ...
... , , JACKSONVILLE, Fla., Aug. ... most important of the five senses. Yet, new research reveals that across ... translates to good eye health. This and other findings confirm a large ... people from seeking proper treatment and diagnosis for them and their children. ...
... , , NEW YORK, Aug. 6 ... technology shown to significantly help improve the appearance of unwanted discoloration, ... through select physicians to help their patients achieve picture perfect skin. ... found in leading physician offices for $120 per 1 ounce pump. ...
... - Not for Release, Publication or Distribution Directly or Indirectly in, ... any Other Jurisdiction in Which Such Publication or Distribution ... is not a Prospectus and is not an Offer to Sell or a, ... United States or, in any Other Jurisdiction, , ...
... , , , ... ) today announced that its Board of Directors has named Daniel J. ... He will join Stereotaxis in September, 2009 and replace James M. ... Company effective at year end 2009. Mr. Johnston brings over 15 ...
Cached Medicine News:Health News:U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 2Health News:U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 3Health News:Former Microsoft Healthcare Executive Joins iMedExchange 2Health News:Worldwide Gap Between Vision Care Attitudes & Behavior 2Health News:Worldwide Gap Between Vision Care Attitudes & Behavior 3Health News:Worldwide Gap Between Vision Care Attitudes & Behavior 4Health News:Worldwide Gap Between Vision Care Attitudes & Behavior 5Health News:Photos: Lumixyl(TM) Enters the Market to Improve the Appearance of Hyperpigmentation without Irritation and Side Effects 2Health News:Photos: Lumixyl(TM) Enters the Market to Improve the Appearance of Hyperpigmentation without Irritation and Side Effects 3Health News:EANS-News: Alapis Announces its Share Capital Increase to Raise c. EUR 451.1 million 2Health News:EANS-News: Alapis Announces its Share Capital Increase to Raise c. EUR 451.1 million 3Health News:Stereotaxis Names Daniel Johnston as Chief Financial Officer 2Health News:Stereotaxis Names Daniel Johnston as Chief Financial Officer 3
(Date:5/23/2013)...  The need to add tissue preserving therapies ... prominently at the 108 th Annual Meeting ... Diego.  According to SonaCare Medical, a leader in ... the need for image-guided technologies to better identify ... minimally invasive ablative treatments, was addressed in the ...
(Date:5/23/2013)... 23, 2013  Every day, their baby stopped breathing, his ... lungs. April and Bryan Gionfriddo watched ... "Quite a few doctors said he had a ... April Gionfriddo , about her now 20-month-old son, ... work, we would take it and run with it." ...
(Date:5/23/2013)... Mass. , May 23, 2013  Hologic, ... HOLX ), a leading developer, manufacturer and supplier ... products, with an emphasis on serving the healthcare ... large-scale observational study in a U.S. clinical practice ... technology (breast tomosynthesis) with conventional 2D mammography alone ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... , , , , , , CAPUA, ... has entered into an agreement with Laboratoires Mayoly Spindler, Chatou ... has successfully completed process development and commenced cGMP manufacture of ... clinical needs. DSM BioSolutions manufactures the lipase compound at its ...
... , ALISO VIEJO, Calif., Dec. 21 Clarient, Inc. (Nasdaq: ... pathologists, oncologists and the pharmaceutical industry, today announced that it ... in an all-stock merger valued at up to $17.6 million, ... agreement are successfully met. As a result of the ...
Cached Medicine Technology:DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 2DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 3DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 4Clarient Acquires Applied Genomics, Inc. 2Clarient Acquires Applied Genomics, Inc. 3Clarient Acquires Applied Genomics, Inc. 4Clarient Acquires Applied Genomics, Inc. 5Clarient Acquires Applied Genomics, Inc. 6Clarient Acquires Applied Genomics, Inc. 7
Ultra-Slip™ endotracheal tube guide for single-patient use only., ,Caution: Not MRI Compatible....
FlexiSlip™ Plastic coated malleable metal core. Single use, Sterile, Latex Free. Soft distal tip flexes to reduce risk of trauma to patient. Malleable metal core is easy to shape. Low friction ...
Endotracheal Tube Stylet- Adult, Copper, Malleable, Non-Sterile, Latex Free, Suitable for tubes 5.0 mm I.D. or larger....
... Prevent dental and soft tissue damage. Used ... X-ray. Light-guided intubation is based upon the ... neck. This technique takes advantage of the ... the esophagus. A well-defined, circumscribed glow can ...
Medicine Products: